Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada (SI, SW, JR, HAH, YTN, CMW, TE-M); Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada (SW, JR, HAH, CMW, TE-M); Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada (SW, JR, HAH, CMW, TE-M); Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada (SW, TE-M); Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada (JR); Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada (JR); Institute for Clinical Psychology and Psychotherapy, TU Dresden, Dresden, Germany (JR); Department of International Health Projects, Institute for Leadership and Health Management, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation (JR); Institute for Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada (CMW); Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada (CMW); Information Management, Centre for Addiction and Mental Health, Toronto, Ontario, Canada (DJ); Department of Health Sciences, Lakehead University, Thunder Bay, Ontario, Canada (TE-M).
J Addict Med. 2021;15(6):484-490. doi: 10.1097/ADM.0000000000000798.
In the context of the ongoing coronavirus disease pandemic in Canada, we aimed to (1) characterize trends in cannabis use in the overall population; and (2) characterize patterns of and identify risk characteristics associated with an increase in cannabis use among those who used cannabis.
Data were obtained from three waves of an online, repeated cross-sectional survey of adults residing in Canada (May 08-June 23, 2020; N = 3012). Trends were assessed using Cochran-Armitage and chi-square tests, and risk characteristics were identified using logistic regression analyses.
Cannabis use in the overall population remained stable during the months of May and June. Among those who used cannabis, about half increased their cannabis use compared to before the start of the pandemic. This proportion of an increase in cannabis use among those who used cannabis remained consistent across the survey waves. Risk characteristics associated with higher odds of an increase in cannabis use included residence in the central region (Odds ratio, 95% confidence intervals: 1.93, 1.03-3.62), being 18 to 29 years old (2.61, 1.32-5.17) or 30 to 49 years old (1.85, 1.07-3.19), having less than college or university education (1.86, 1.13-3.06) and being somewhat worried about the pandemic's impact on personal finances (1.73, 1.00-3.00).
A large proportion of those who used cannabis have increased cannabis use during the pandemic, suggesting a need for interventions to limit increased cannabis use, policy measures to address cannabis-attributable harms, and continued monitoring of cannabis use during and after the pandemic.
在加拿大当前冠状病毒病大流行的背景下,我们旨在:(1)描述普通人群中大麻使用的趋势;(2)描述在使用大麻的人群中,大麻使用增加的模式,并确定与之相关的风险特征。
数据来自于加拿大成年人的三次在线重复横断面调查(2020 年 5 月 8 日至 6 月 23 日;N=3012)。使用 Cochran-Armitage 和卡方检验评估趋势,使用逻辑回归分析确定风险特征。
在 5 月和 6 月期间,普通人群中大麻使用保持稳定。在使用大麻的人群中,大约一半人比大流行前增加了大麻使用。在整个调查期间,使用大麻的人群中增加大麻使用的比例保持一致。与大麻使用增加的更高几率相关的风险特征包括居住在中部地区(优势比,95%置信区间:1.93,1.03-3.62)、18 至 29 岁(2.61,1.32-5.17)或 30 至 49 岁(1.85,1.07-3.19)、受教育程度低于大学或大专(1.86,1.13-3.06)以及对大流行对个人财务影响有些担心(1.73,1.00-3.00)。
在大流行期间,很大一部分使用大麻的人增加了大麻使用,这表明需要采取干预措施来限制大麻使用的增加,采取政策措施解决与大麻相关的危害,并在大流行期间和之后继续监测大麻使用情况。